Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Paul Duffy & Adam John Mackridge. (2014) Use and diversion of illicit methadone – under what circumstances does it occur, and potential risks associated with continued use of other substances. Journal of Substance Use 19:1-2, pages 48-55.
Read now
Read now
Helen Baldwin & Paul Duffy. (2013) Drug treatment practitioners’ perceptions of methadone diversion and their responses to it. Drugs: Education, Prevention and Policy 20:1, pages 22-32.
Read now
Read now
Amy Wachholtz, Gerardo Gonzalez, Edward Boyer, Zafar N Naqvi, Christopher Rosenbaum & Douglas Ziedonis. (2011) Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Substance Abuse and Rehabilitation 2, pages 145-162.
Read now
Read now
Amy Wachholtz, Douglas Ziedonis & Gerardo Gonzalez. (2011) Comorbid Pain and Opioid Addiction: Psychosocial and Pharmacological Treatments. Substance Use & Misuse 46:12, pages 1536-1552.
Read now
Read now
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2009) Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland. American Journal on Addictions 18:5, pages 346-355.
Read now
Read now
Articles from other publishers (25)
Arianna Giorgetti, Jennifer Pascali, Massimo Montisci, Irene Amico, Barbara Bonvicini, Paolo Fais, Alessia Viero, Raffaele Giorgetti, Giovanni Cecchetto & Guido Viel. (2021) The Role of Risk or Contributory Death Factors in Methadone-Related Fatalities: A Review and Pooled Analysis. Metabolites 11:3, pages 189.
Crossref
Crossref
Omid Mehrpour, Christopher Hoyte, Alireza Amirabadizadeh & Jeffrey Brent. (2020) Clinical characteristics and time trends of hospitalized methadone exposures in the United States based on the Toxicology Investigators Consortium (ToxIC) case registry: 2010–2017. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Lisa Andersson, Anders Håkansson, Peter Krantz & Björn Johnson. (2020) Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances. Harm Reduction Journal 17:1.
Crossref
Crossref
Leila Ahmad-Molaei, Hossein Hassanian-Moghaddam, Fariba Farnaghi, Carlos Tomaz & Abbas Haghparast. (2018) Delay-Dependent Impairments in Memory and Motor Functions After Acute Methadone Overdose in Rats. Frontiers in Pharmacology 9.
Crossref
Crossref
Andrew S. Huhn & Kelly E. Dunn. (2017) Why aren't physicians prescribing more buprenorphine?. Journal of Substance Abuse Treatment 78, pages 1-7.
Crossref
Crossref
Kenneth Blum, David Han, John Femino, David E. Smith, Scott Saunders, Thomas Simpatico, Stephen J. Schoenthaler, Marlene Oscar-Berman & Mark S. Gold. (2014) Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs. PLoS ONE 9:9, pages e104275.
Crossref
Crossref
Abbas Aghabiklooei, Maryam Edalatparvar, Nasim Zamani & Babak Mostafazadeh. (2014) Prognostic Factors in Acute Methadone Toxicity: A 5-Year Study. Journal of Toxicology 2014, pages 1-6.
Crossref
Crossref
Nancy Hardt, Tit D. Wong, Martha J. Burt, Ross Harrison, Will Winter & Jeffrey Roth. (2013) Prevalence of Prescription and Illicit Drugs in Pregnancy‐Associated Non‐natural Deaths of Florida Mothers, 1999–2005. Journal of Forensic Sciences 58:6, pages 1536-1541.
Crossref
Crossref
Erin K. Sauber-Schatz, Karin A. Mack, Shane T. Diekman & Leonard J. Paulozzi. (2013) Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida. Drug and Alcohol Dependence 133:1, pages 161-166.
Crossref
Crossref
David L. Nordstrom, Mieko L. Yokoi-Shelton & Amy Zosel. (2013) Using Multiple Cause-of-Death Data to Improve Surveillance of Drug-Related Mortality. Journal of Public Health Management and Practice 19:5, pages 402-411.
Crossref
Crossref
Aaron J Bagnola & Alisa K Escaño. (2013) Identifying Potential Causes of Opioid Toxicity Necessitating a Rapid Response Team Visit. Journal of Pharmacy Technology 29:3, pages 118-122.
Crossref
Crossref
Alexander Y. Walley, Maya Doe-Simkins, Emily Quinn, Courtney Pierce, Ziming Xuan & Al Ozonoff. (2013) Opioid overdose prevention with intranasal naloxone among people who take methadone. Journal of Substance Abuse Treatment 44:2, pages 241-247.
Crossref
Crossref
Jean-Paul Bernard, Ingrid Havnes, Lars Sl?rdal, Helge Waal, J?rg M?rland & Hassan Z. Khiabani. (2013) Methadone-related deaths in Norway. Forensic Science International 224:1-3, pages 111-116.
Crossref
Crossref
Paul Duffy & Helen Baldwin. (2012) The nature of methadone diversion in England: a Merseyside case study. Harm Reduction Journal 9:1, pages 3.
Crossref
Crossref
Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum & Richard C. Dart. (2010) Post-marketing Surveillance of Methadone and Buprenorphine in the United States. Pain Medicine 11:7, pages 1078-1091.
Crossref
Crossref
Kai Yuan, Wei Qin, Jixin Liu, Qian Guo, Minghao Dong, Jinbo Sun, Yi Zhang, Peng Liu, Wei Wang, Yarong Wang, Qiang Li, Weichuan Yang, Karen M. von Deneen, Mark S. Gold, Yijun Liu & Jie Tian. (2010) Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals. Neuroscience Letters 477:1, pages 37-42.
Crossref
Crossref
Vania Modesto-Lowe, Donna Brooks & Nancy Petry. (2010) Methadone Deaths: Risk Factors in Pain and Addicted Populations. Journal of General Internal Medicine 25:4, pages 305-309.
Crossref
Crossref
Peter C. Britton, James D. WinesJr.Jr. & Kenneth R. Conner. (2010) Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug and Alcohol Dependence 107:1, pages 51-55.
Crossref
Crossref
Jane Carlisle Maxwell & Elinore F. McCance‐Katz. (2009) Indicators of Buprenorphine and Methadone Use and Abuse: What Do We Know?. The American Journal on Addictions 19:1, pages 73-88.
Crossref
Crossref
Wesley D. McMillian & Sheila C. Gencarelli. (2009) Development of a methadone order form for inpatients. American Journal of Health-System Pharmacy 66:23, pages 2076-2083.
Crossref
Crossref
Felix K. Adatsi. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2010) Uses of Diverted Methadone and Buprenorphine by Opioid‐Addicted Individuals in Baltimore, Maryland. The American Journal on Addictions 18:5, pages 346-355.
Crossref
Crossref
Leonard J. Paulozzi, Joseph E. Logan, Aron J. Hall, Edna McKinstry, James A. Kaplan & Alexander E. Crosby. (2009) A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 104:9, pages 1541-1548.
Crossref
Crossref
David R.P. Guay. (2009) Cardiotoxicity of Oral Methadone as an Analgesic–-Recommendations for Safe Use. Clinical Medicine. Therapeutics 1, pages CMT.S3041.
Crossref
Crossref
Adam J. Gordon, David A. Fiellin, Peter D. Friedmann, Marc N. Gourevitch, Kevin L. Kraemer, Julia H. Arnsten & Richard Saitz. (2008) Update in Addiction Medicine for the Primary Care Clinician. Journal of General Internal Medicine 23:12, pages 2112-2116.
Crossref
Crossref